LTF4 is a cysteinyl-leukotriene produced in vitro, but not reported to date in vivo. It is formed by the incubation of LTE4 with γ-glutamyl transpeptidase and glutathione. LTF4 is a weak agonist in its ability to contract vascular smooth muscle.1 The rank order of potency of the cysteinyl-leukotrienes to contract vascular smooth muscle is LTD4 > LTC4 > LTE4 >> LTF4.1,2
1
Bernstrom, K., and Hammarström, S. A novel leukotriene formed by transpeptidation of leukotriene E4. Biochem Biophys Res Commun109800-804(1982).
2
Lord, A., Charleson, S., and Letts, L.G. Leukotriene F4 and the release of arachidonic acid metabolites from perfused guinea pig lungs in vitro. Prostaglandins29651-660(1985).
Bernstrom, K., and Hammarström, S. A novel leukotriene formed by transpeptidation of leukotriene E4. Biochem Biophys Res Commun109800-804(1982).
Lord, A., Charleson, S., and Letts, L.G. Leukotriene F4 and the release of arachidonic acid metabolites from perfused guinea pig lungs in vitro. Prostaglandins29651-660(1985).
Leukotriene F4 is available in the following screening
library: